A new research conducted at a massive scale has found that postmenopausal women consuming drugs to reduce cholesterol called statins are not decreasing their chances to have colorectal cancer.

Several earlier studies have shown that statins could decrease the risk of colorectal cancer; however, the findings of this new research involving more than 150,000 women found that the risk has not reduced independent of the kind of statin taken and for what duration.

Lead researcher Dr. Michael S. Simon, a professor of oncology at Wayne State University in Detroit, said during a Monday afternoon press conference, "The upshot was there was no significant difference in colorectal cancer risk between statin users and nonusers."

The findings were due to be revealed at the American Association for Cancer Research's ninth annual Frontiers in Cancer Prevention Research Conference which will finish this week in Philadelphia.

Simon said that findings from earlier studies have revealed that a small decrease in colorectal cancer risk in those who use statins, however, most studies have not been able to find any relation between the use of statin and decrease in colorectal cancer risk.